dc.contributor.author |
Анваров Ж.А., Шербекова Д.У., Норкизилова Г.О. |
|
dc.date.accessioned |
2024-05-13T10:35:24Z |
|
dc.date.available |
2024-05-13T10:35:24Z |
|
dc.date.issued |
2024 |
|
dc.identifier.citation |
International journal of scientific researchers.-Volume 5.-Issue 1.-2024.-Р.558-560 |
en_US |
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/10983 |
|
dc.description.abstract |
Cerebral echinococcosis presents a challenging clinical entity characterized by the formation of cystic lesions within the brain.
The disease's clinical manifestations vary widely, ranging from asymptomatic cases to severe neurological deficits and life-threatening complications. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and serological tests. Treatment strategies often include a multidisciplinary approach, incorporating medical therapy with
anthelmintic drugs and surgical intervention when necessary. Despite advances in diagnosis and treatment, the management of cerebral echinococcosis remains complex, requiring ongoing research efforts to improve our understanding of the disease's epidemiology, pathogenesis. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Ташкент, Узбекистан |
en_US |
dc.subject |
Echinococcus tapeworms , MRI, Albendazole, interacerbral cystic formation, lung forms |
en_US |
dc.title |
Case of cerebral echinococcosis |
en_US |
dc.type |
Article |
en_US |